한국어
English
日本語
中文(简体)
Volibris Tablets 5 mg (Ambrisentan)
5mg
Tablet · Prescription medication
GlaxoSmithKline Co., Ltd.
Ambrisentan is a antihypertensive component used for the treatment of pulmonary arterial hypertension.
MFDS ingredient code M246197
Ambrisentan is a component of the antihypertensive class that acts to dilate blood vessels. It is primarily used to lower blood pressure and reduce vascular resistance in patients with pulmonary arterial hypertension. This helps to reduce the strain on the heart and alleviate symptoms.
Ambrisentan works by blocking specific receptors in the blood vessels to prevent them from narrowing. As a result, the blood vessels in the pulmonary artery dilate, leading to lowered blood pressure and improved blood flow. Consequently, the strain on the heart is reduced, and symptoms are alleviated.
Approved uses differ by product. Check each product's information for its actual use.
Ambrisentan has the characteristic of selectively blocking vascular receptors, providing specialized effects for pulmonary arterial hypertension compared to other antihypertensives. As a result, the impact on systemic blood pressure is relatively minor.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
